Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05670743 · ClinicalTrials.gov registry record · Phase 2
Pharmacokinetics of Advantage Arrest in Healthy Children 13-Months to 13-Years of Age
A Phase 2 study of Dental Caries in Children, sponsored by Advantage Silver Dental Arrest.
- Completed
- Registry status
- Phase 2
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT05670743 is a Phase 2 study of Dental Caries in Children that has completed, run by Advantage Silver Dental Arrest. The registered enrollment target is 23 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05670743, a Phase 2 study of Dental Caries in Children, has completed, sponsored by Advantage Silver Dental Arrest.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to further characterize basic pharmacokinetic (PK) parameters in healthy children to contribute to evidence for the safety of silver diamine fluoride (SDF; Advantage Arrest). Children with at least one active cavity will be treated and then have blood draws at random time points afterwards.
Conditions Studied
Interventions
- DRUG 38% silver diamine fluoride
Study Locations (1)
Washington
- Center for Pediatric Dentistry - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-03-01 |
| Est. Completion | 2024-08-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05670743
The ClinicalTrials.gov registry entry for NCT05670743 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Advantage Silver Dental Arrest, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Dental Caries in Children appearing as the primary indexed condition, and to 1 intervention - of which 38% silver diamine fluoride is the first listed.
NCT05670743 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT05670743 about?
NCT05670743 is a clinical study titled "Pharmacokinetics of Advantage Arrest in Healthy Children 13-Months to 13-Years of Age". The purpose of this study is to further characterize basic pharmacokinetic (PK) parameters in healthy children to contribute to evidence for the safety of silver diamine fluoride (SDF; Advantage Arrest). Children with at least one active cavity will be treated and then have blood draws at random tim...
What is the current status of trial NCT05670743?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 23 participants. The study started on 2023-03-01. Estimated completion is 2024-08-01.
What conditions does trial NCT05670743 study?
This clinical trial studies the following conditions: Dental Caries in Children.
What interventions are being tested in trial NCT05670743?
The interventions under investigation include: 38% silver diamine fluoride (DRUG).
Who is sponsoring clinical trial NCT05670743?
This trial is sponsored by Advantage Silver Dental Arrest, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05670743 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dental Caries in Children
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.